Referral Pattern of Breast Cancer Patients Treated with Tamoxifen or Aromatase Inhibitors to Gynaecology.
OBJECTIVES Tamoxifen and Aromatase Inhibitors are commonly used as adjuvant treatment for estrogen receptor positive (ER+) breast cancer. Our objective was to evaluate the gynecological referral of breast cancer patients treated with tamoxifen or aromatase inhibitors. METHODS We conducted a retrospective cohort study...